Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Thyroid cancer incidence near nuclear sites in Belgium: An ecological study at small geographical level.

Demoury C, De Schutter H, Faes C, Carbonnelle S, Fierens S, Molenberghs G, Van Damme N, Van Bladel L, Van Nieuwenhuyse A, Vleminckx C.

Int J Cancer. 2019 Nov 19. doi: 10.1002/ijc.32796. [Epub ahead of print]

PMID:
31745983
2.

Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy.

Tosco L, Devos G, De Coster G, Roumeguère T, Everaerts W, Quackels T, Dekuyper P, Van Cleynenbreugel B, Van Damme N, Van Eycken E, Ameye F, Joniau S; Be-RALP(Belgian Robotic-Assisted Laparoscopic Prostatectomy Registry): The Belgian RALP Consortium.

Urol Oncol. 2020 Feb;38(2):37.e11-37.e20. doi: 10.1016/j.urolonc.2019.10.001. Epub 2019 Nov 12.

PMID:
31727561
3.

Physiological processes of inflammation and edema initiated by sustained mechanical loading in subcutaneous tissues: A scoping review.

Van Damme N, Van Hecke A, Remue E, Van den Bussche K, Moore Z, Gefen A, Verhaeghe S, Beeckman D.

Wound Repair Regen. 2019 Nov 2. doi: 10.1111/wrr.12777. [Epub ahead of print] Review.

PMID:
31677314
4.

Modifiable patient-related factors associated with pressure ulcers on the sacrum and heels: Secondary data analyses.

Manderlier B, Van Damme N, Verhaeghe S, Van Hecke A, Everink I, Halfens R, Beeckman D.

J Adv Nurs. 2019 Jul 9. doi: 10.1111/jan.14149. [Epub ahead of print]

PMID:
31287188
5.

The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research.

Vande Loock K, Van der Stock E, Debucquoy A, Emmerechts K, Van Damme N, Marbaix E.

Front Med (Lausanne). 2019 May 31;6:120. doi: 10.3389/fmed.2019.00120. eCollection 2019.

6.

Outcome measurement instruments for erythema associated with incontinence-associated dermatitis: Systematic review.

De Meyer D, Gabriel S, Kottner J, Van Damme N, Van den Bussche K, Verhaeghe S, Van Hecke A, Beeckman D.

J Adv Nurs. 2019 Jun 14. doi: 10.1111/jan.14102. [Epub ahead of print] Review.

PMID:
31197869
7.

Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series.

Tosco L, De Coster G, Roumeguère T, Everaerts W, Quackels T, Dekuyper P, Van Cleynenbreugel B, Van Damme N, Van Eycken E, Ameye F, Joniau S; Be RALP the Belgian RALP consortium.

Eur Urol Oncol. 2018 Sep;1(4):338-345. doi: 10.1016/j.euo.2018.04.008. Epub 2018 Jun 7.

PMID:
31100256
8.

Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.

Claassen YHM, Bastiaannet E, van Eycken E, Van Damme N, Martling A, Johansson R, Iversen LH, Ingeholm P, Lemmens VEPP, Liefers GJ, Holman FA, Dekker JWT, Portielje JEA, Rutten HJ, van de Velde CJH.

Eur J Surg Oncol. 2019 Aug;45(8):1396-1402. doi: 10.1016/j.ejso.2019.03.041. Epub 2019 Apr 9.

PMID:
31003722
9.

Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy.

Poelaert F, Joniau S, Roumeguère T, Ameye F, De Coster G, Dekuyper P, Quackels T, Van Cleynenbreugel B, Van Damme N, Van Eycken E, Mottrie A, Lumen N; Belgian RALP Consortium.

Eur Urol Oncol. 2019 Feb;2(1):110-117. doi: 10.1016/j.euo.2018.05.005. Epub 2018 May 27.

PMID:
30929840
10.

The prevalence and associated factors of skin tears in Belgian nursing homes: A cross-sectional observational study.

Van Tiggelen H, Van Damme N, Theys S, Vanheyste E, Verhaeghe S, LeBlanc K, Campbell K, Woo K, Van Hecke A, Beeckman D.

J Tissue Viability. 2019 May;28(2):100-106. doi: 10.1016/j.jtv.2019.01.003. Epub 2019 Feb 7.

PMID:
30770306
11.

Design and psychometric testing of the attitude towards the prevention of incontinence-associated dermatitis instrument (APrIAD).

Van Damme N, Van Hecke A, Himpens A, Verhaeghe S, Beeckman D.

Int Wound J. 2019 Apr;16(2):492-502. doi: 10.1111/iwj.13062. Epub 2018 Dec 26.

PMID:
30588746
12.

Comparison of Two Methods for Estimating the Tip Position of a Nasogastric Feeding Tube: A Randomized Controlled Trial.

Torsy T, Saman R, Boeykens K, Duysburgh I, Van Damme N, Beeckman D.

Nutr Clin Pract. 2018 Dec;33(6):843-850. doi: 10.1002/ncp.10112. Epub 2018 Jun 30.

PMID:
29959848
13.

Core outcome domains in incontinence-associated dermatitis research.

Van den Bussche K, Kottner J, Beele H, De Meyer D, Dunk AM, Ersser S, Lange T, Petrovic M, Schoonhoven L, Smet S, Van Damme N, Verhaeghe S, Van Hecke A, Beeckman D.

J Adv Nurs. 2018 Jul;74(7):1605-1617. doi: 10.1111/jan.13562. Epub 2018 Apr 6. Review.

PMID:
29520848
14.

Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units.

Van Damme N, Clays E, Verhaeghe S, Van Hecke A, Beeckman D.

Int J Nurs Stud. 2018 May;81:30-39. doi: 10.1016/j.ijnurstu.2018.01.014. Epub 2018 Feb 2.

PMID:
29428583
15.

Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries.

Beeckman D, Van den Bussche K, Alves P, Arnold Long MC, Beele H, Ciprandi G, Coyer F, de Groot T, De Meyer D, Deschepper E, Dunk AM, Fourie A, García-Molina P, Gray M, Iblasi A, Jelnes R, Johansen E, Karadağ A, Leblanc K, Kis Dadara Z, Meaume S, Pokorna A, Romanelli M, Ruppert S, Schoonhoven L, Smet S, Smith C, Steininger A, Stockmayr M, Van Damme N, Voegeli D, Van Hecke A, Verhaeghe S, Woo K, Kottner J.

Br J Dermatol. 2018 Jun;178(6):1331-1340. doi: 10.1111/bjd.16327. Epub 2018 Apr 19.

PMID:
29315488
16.

Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options.

Beele H, Smet S, Van Damme N, Beeckman D.

Drugs Aging. 2018 Jan;35(1):1-10. doi: 10.1007/s40266-017-0507-1. Review.

PMID:
29243033
17.

The inflammatory response to stress and angiogenesis in liver resection for colorectal liver metastases: a randomized controlled trial comparing open versus laparoscopic approach.

Kasai M, Van Damme N, Berardi G, Geboes K, Laurent S, Troisi RI.

Acta Chir Belg. 2018 Jun;118(3):172-180. doi: 10.1080/00015458.2017.1407118. Epub 2017 Nov 27.

PMID:
29179666
18.

Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies.

Boniol M, Franchi M, Bota M, Leclercq A, Guillaume J, van Damme N, Corrao G, Autier P, Boyle P.

Diabetes Care. 2018 Feb;41(2):286-292. doi: 10.2337/dc17-0280. Epub 2017 Nov 16.

PMID:
29146599
19.

Thyroid Cancer Incidence around the Belgian Nuclear Sites, 2000-2014.

Demoury C, De Smedt T, De Schutter H, Sonck M, Van Damme N, Bollaerts K, Molenberghs G, Van Bladel L, Van Nieuwenhuyse A.

Int J Environ Res Public Health. 2017 Aug 31;14(9). pii: E988. doi: 10.3390/ijerph14090988.

20.

Current trends in patient enrollment for robotic-assisted laparoscopic prostatectomy in Belgium.

Albisinni S, Joniau S, Quackels T, De Coster G, Dekuyper P, Van Cleynenbreugel B, Van Damme N, Van Eycken E, Ameye F, Roumeguère T; Be-RALP Registry (Belgian Robotic-Assisted Laparoscopic Prostatectomy Registry).

Cancer. 2017 Nov 1;123(21):4139-4146. doi: 10.1002/cncr.30874. Epub 2017 Jul 25.

21.

Development and psychometric validation of PUKAT 2·0, a knowledge assessment tool for pressure ulcer prevention.

Manderlier B, Van Damme N, Vanderwee K, Verhaeghe S, Van Hecke A, Beeckman D.

Int Wound J. 2017 Dec;14(6):1041-1051. doi: 10.1111/iwj.12758. Epub 2017 May 26.

PMID:
28547752
22.

The Impact of a Teaching or Singing Career on the Female Vocal Quality at the Mean Age of 67 Years: A Pilot Study.

D'haeseleer E, Claeys S, Bettens K, Leemans L, Van Calster AS, Van Damme N, Thijs Z, Daelman J, Leyns C, Van Lierde K.

J Voice. 2017 Jul;31(4):516.e19-516.e26. doi: 10.1016/j.jvoice.2016.12.016. Epub 2017 Feb 7.

PMID:
28187923
23.

Independent risk factors for the development of skin erosion due to incontinence (incontinence-associated dermatitis category 2) in nursing home residents: results from a multivariate binary regression analysis.

Van Damme N, Van den Bussche K, De Meyer D, Van Hecke A, Verhaeghe S, Beeckman D.

Int Wound J. 2017 Oct;14(5):801-810. doi: 10.1111/iwj.12699. Epub 2016 Dec 9.

PMID:
27933731
24.

Interventions for preventing and treating incontinence-associated dermatitis in adults.

Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, Verhaeghe S.

Cochrane Database Syst Rev. 2016 Nov 10;11:CD011627. Review.

25.

PROTECT - trial: a multicentre prospective pragmatic RCT and health economic analysis of the effect of tailored repositioning to prevent pressure ulcers - study protocol.

De Meyer D, Van Damme N, Van den Bussche K, Van Hecke A, Verhaeghe S, Beeckman D.

J Adv Nurs. 2017 Feb;73(2):495-503. doi: 10.1111/jan.13166. Epub 2016 Oct 20.

PMID:
27682442
26.

CONSIDER - Core Outcome Set in IAD Research: study protocol for establishing a core set of outcomes and measurements in incontinence-associated dermatitis research.

Van den Bussche K, De Meyer D, Van Damme N, Kottner J, Beeckman D.

J Adv Nurs. 2017 Oct;73(10):2473-2483. doi: 10.1111/jan.13165. Epub 2016 Oct 17.

PMID:
27682261
27.

Review of the quality of total mesorectal excision does not improve the prediction of outcome.

Demetter P, Jouret-Mourin A, Silversmit G, Vandendael T, Sempoux C, Hoorens A, Nagy N, Cuvelier C, Van Damme N, Penninckx F; PROCARE.

Colorectal Dis. 2016 Sep;18(9):883-8. doi: 10.1111/codi.13254.

PMID:
27586703
28.

Ovarian cancer in children and adolescents: A rare disease that needs more attention.

Baert T, Storme N, Van Nieuwenhuysen E, Uyttebroeck A, Van Damme N, Vergote I, Coosemans A.

Maturitas. 2016 Jun;88:3-8. doi: 10.1016/j.maturitas.2016.03.003. Epub 2016 Mar 8. Review.

PMID:
27105689
29.

Development of a Quality of Meals and Meal Service Set of Indicators for Residential Facilities for Elderly.

Van Damme N, Buijck B, Van Hecke A, Verhaeghe S, Goossens E, Beeckman D.

J Nutr Health Aging. 2016;20(5):471-7. doi: 10.1007/s12603-015-0627-4. Review.

PMID:
27102782
30.

Proton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers.

Leroy R, Benahmed N, Hulstaert F, Van Damme N, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):267-78. doi: 10.1016/j.ijrobp.2015.10.025. Epub 2015 Oct 17. Review.

PMID:
27084646
31.

Quality of pathology reporting is crucial for cancer care and registration: a baseline assessment for breast cancers diagnosed in Belgium in 2008.

De Schutter H, Van Damme N, Colpaert C, Galant C, Lambein K, Cornelis A, Neven P, Van Eycken E.

Breast. 2015 Apr;24(2):143-52. doi: 10.1016/j.breast.2014.12.004. Epub 2015 Jan 5.

PMID:
25572136
32.

Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.

Debergh I, Van Damme N, De Naeyer D, Smeets P, Demetter P, Robert P, Carme S, Pattyn P, Ceelen W.

Ann Surg Oncol. 2014 Jun;21(6):2097-104. doi: 10.1245/s10434-013-3444-1. Epub 2013 Dec 20.

PMID:
24356800
33.

Molecular and electronic structures of complexes containing 1-(2-pyridylazo)-2-phenanthrol (PAPL): revisiting a redox-active ligand.

Van Damme N, Lough AJ, Gorelsky SI, Lemaire MT.

Inorg Chem. 2013 Nov 18;52(22):13021-8. doi: 10.1021/ic401618u. Epub 2013 Oct 30.

PMID:
24171483
34.

Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma.

Ky V, Hav M, Berrevoet F, Troisi RI, Ferdinande L, Monsaert E, Vanderstraeten E, De Bosschere K, Van Damme N, Laurent S, Geboes K.

Pancreas. 2013 Oct;42(7):1138-42. doi: 10.1097/MPA.0b013e31829a80b7.

PMID:
24048454
35.

Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.

Mertens J, De Bruyne S, Van Damme N, Smeets P, Ceelen W, Troisi R, Laurent S, Geboes K, Peeters M, Goethals I, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1214-22. doi: 10.1007/s00259-013-2421-z. Epub 2013 May 1.

PMID:
23636802
36.

Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?

Mees G, Dierckx R, Vangestel C, Laukens D, Van Damme N, Van de Wiele C.

Mol Imaging. 2013 Jan-Feb;12(1):49-58.

PMID:
23348791
37.

Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.

Pringels S, Van Damme N, De Craene B, Pattyn P, Ceelen W, Peeters M, Grooten J.

BMC Cancer. 2012 Nov 13;12:515. doi: 10.1186/1471-2407-12-515.

38.

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.

De Bruyne S, Van Damme N, Smeets P, Ferdinande L, Ceelen W, Mertens J, Van de Wiele C, Troisi R, Libbrecht L, Laurent S, Geboes K, Peeters M.

Br J Cancer. 2012 Jun 5;106(12):1926-33. doi: 10.1038/bjc.2012.184. Epub 2012 May 17.

39.

Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.

Vangestel C, Van de Wiele C, Mees G, Mertens K, Staelens S, Reutelingsperger C, Pauwels P, Van Damme N, Peeters M.

Mol Imaging. 2012 Apr;11(2):135-47.

PMID:
22469241
40.

99mTc-labeled tricarbonyl his-CNA35 as an imaging agent for the detection of tumor vasculature.

Mees G, Dierckx R, Mertens K, Vermeire S, Van Steenkiste M, Reutelingsperger C, D'Asseler Y, Peremans K, Van Damme N, Van de Wiele C.

J Nucl Med. 2012 Mar;53(3):464-71. doi: 10.2967/jnumed.111.095794. Epub 2012 Feb 13.

41.

(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.

Vangestel C, Van de Wiele C, Van Damme N, Staelens S, Pauwels P, Reutelingsperger CP, Peeters M.

J Nucl Med. 2011 Nov;52(11):1786-94. doi: 10.2967/jnumed.111.092650.

42.

Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.

Delrue LJ, Casneuf V, Van Damme N, Blanckaert P, Peeters M, Ceelen WP, Duyck PC.

MAGMA. 2011 Aug;24(4):225-32. doi: 10.1007/s10334-011-0256-9. Epub 2011 May 13.

PMID:
21567161
43.

In vivo imaging of apoptosis in oncology: an update.

Vangestel C, Peeters M, Mees G, Oltenfreiter R, Boersma HH, Elsinga PH, Reutelingsperger C, Van Damme N, De Spiegeleer B, Van de Wiele C.

Mol Imaging. 2011 Oct;10(5):340-58. doi: 10.2310/7290.2010.00058. Epub 2011 Apr 26. Review.

PMID:
21521554
44.

Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model.

Bouquet W, Deleye S, Staelens S, De Smet L, Van Damme N, Debergh I, Ceelen WP, De Vos F, Remon JP, Vervaet C.

Pharm Res. 2011 Jul;28(7):1653-60. doi: 10.1007/s11095-011-0401-1. Epub 2011 Mar 18.

PMID:
21424162
45.

Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.

Mees G, Vangestel C, Dierckx R, Loomans S, Van Damme N, Peremans K, De Rooster H, Van Goethem B, Pauwels P, Ducatelle R, Van de Wiele C.

Res Vet Sci. 2011 Dec;91(3):e125-8. doi: 10.1016/j.rvsc.2011.01.014. Epub 2011 Feb 12.

PMID:
21316722
46.

Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent.

Casneuf VF, Delrue L, Van Damme N, Demetter P, Robert P, Corot C, Duyck P, Ceelen W, Boterberg T, Peeters M.

Radiat Res. 2011 Jan;175(1):10-20. doi: 10.1667/RR2068.1. Epub 2010 Oct 7.

PMID:
21175342
47.

In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.

Vangestel C, Peeters M, Oltenfreiter R, D'Asseler Y, Staelens S, Van Steenkiste M, Philippé J, Kusters D, Reutelingsperger C, Van Damme N, Van de Wiele C.

Nucl Med Biol. 2010 Nov;37(8):965-75. doi: 10.1016/j.nucmedbio.2010.06.007. Epub 2010 Sep 20.

PMID:
21055628
48.

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.

Van Damme N, Deron P, Van Roy N, Demetter P, Bols A, Van Dorpe J, Baert F, Van Laethem JL, Speleman F, Pauwels P, Peeters M.

BMC Cancer. 2010 May 11;10:189. doi: 10.1186/1471-2407-10-189.

49.

The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.

Debergh I, Van Damme N, Pattyn P, Peeters M, Ceelen WP.

Br J Cancer. 2010 Mar 2;102(5):837-43. doi: 10.1038/sj.bjc.6605535. Epub 2010 Feb 2.

50.

Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.

Mees G, Fonteyne P, Ceelen W, Boterberg T, Pauwels P, Vangestel C, Van Damme N, Peeters M, Dierckx R, Van De Wiele C.

Cancer Biother Radiopharm. 2009 Oct;24(5):565-72. doi: 10.1089/cbr.2009.0621.

PMID:
19877886

Supplemental Content

Loading ...
Support Center